Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Combined Computational And Experimental Studies Of Molecular Interactions Of Albuterol Sulfate With Bovine Serum Albumin For Pulmonary Drug Nanoparticles

Shaohui Lin, W. Cui, G. Wang, S. Meng, Y. Liu, Hong-wei Jin, Liang-ren Zhang, Y. Xie
Published 2016 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Albumin-based nanoparticles (NPs) are a promising technology for developing drug-carrier systems, with improved deposition and retention profiles in lungs. Improved understanding of these drug–carrier interactions could lead to better drug-delivery systems. The present study combines computational and experimental methods to gain insights into the mechanism of binding of albuterol sulfate (AS) to bovine serum albumin (BSA) on the molecular level. Molecular dynamics simulation and surface plasmon resonance spectroscopy were used to determine that there are two binding sites on BSA for AS: the first of which is a high-affinity site corresponding to AS1 and the second of which appears to represent the integrated functions of several low-affinity sites corresponding to AS2, AS3, and AS8. AS1 was the strongest binding site, established via electrostatic interaction with Glu243 and Asp255 residues in a hydrophobic pocket. Hydrogen bonds and salt bridges played a main role in the critical binding of AS1 to BSA, and water bridges served a supporting role. Based upon the interaction mechanism, BSA NPs loaded with AS were prepared, and their drug-loading efficiency, morphology, and -release profiles were evaluated. Successful clinical development of AS-BSA-NPs may improve therapy and prevention of bronchospasm in patients with reversible obstructive airway disease, and thus provide a solid basis for expanding the role of NPs in the design of new drug-delivery systems.
This paper references
10.1016/S0928-0987(00)00169-X
Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.
M. Merodio (2001)
10.1063/1.447334
A unified formulation of the constant temperature molecular dynamics methods
Shūichi Nosé (1984)
10.1016/J.JLUMIN.2016.01.029
Fluorescence spectral studies on interaction of fluorescent probes with Bovine Serum Albumin (BSA)
K. Ghosh (2016)
10.1038/364362B0
Atomic structure and chemistry of human serum albumin
X. M. He (1993)
10.1002/jcc.10349
A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations
Y. Duan (2003)
10.1002/(SICI)1096-987X(199709)18:12%3C1463::AID-JCC4%3E3.0.CO;2-H
LINCS: A linear constraint solver for molecular simulations
B. Hess (1997)
10.3390/bios5010027
Kinetic Analyses of Data from a Human Serum Albumin Assay Using the liSPR System
A. Henseleit (2015)
10.1152/AJPLUNG.00235.2002
Protein transport across the lung epithelial barrier.
K. Kim (2003)
10.1089/adt.2015.649
Development of a Surface Plasmon Resonance Assay for the Characterization of Small-Molecule Binding Kinetics and Mechanism of Binding to Kynurenine 3-Monooxygenase.
Suresh B Poda (2015)
Binding of antiinflammatory drug cromolyn sodium to bovine serum albumin
Yj Hu (2006)
10.2147/DDDT.S74061
Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation
Jiao-Yu He (2014)
10.1021/jp5041713
Modeling the interaction of interferon α-1b to bovine serum albumin as a drug delivery system.
Q. Luo (2014)
10.1016/J.IJBIOMAC.2006.04.004
Binding of anti-inflammatory drug cromolyn sodium to bovine serum albumin.
Y. Hu (2006)
10.1021/JP044185Y
Protein/ligand binding free energies calculated with quantum mechanics/molecular mechanics.
F. Gräter (2005)
10.1186/1556-276X-9-343
Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear
Z. Yu (2014)
Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver target
M Merodio (2008)
10.1016/j.molimm.2012.05.011
Structural and immunologic characterization of bovine, horse, and rabbit serum albumins.
K. Majorek (2012)
10.1126/SCIENCE.276.5320.1868
Large porous particles for pulmonary drug delivery.
D. Edwards (1997)
10.1002/ppul.23469
Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe
F. P. Muchão (2016)
10.1016/j.jconrel.2011.07.031
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
10.1002/jcc.20290
The Amber biomolecular simulation programs
D. A. Case (2005)
10.1016/j.pupt.2016.01.001
Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model.
J. Seo (2016)
10.1021/acs.molpharmaceut.5b00064
Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection.
P. J. Das (2015)
10.2174/1381612822666160128145356
Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.
S. Gharse (2016)
10.1016/j.jconrel.2015.05.269
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
A. Woods (2015)
10.1016/j.ejpb.2008.10.002
Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
J. Albers (2009)
albuterol sulfate–Bsa nPs for pulmonary disease
10.1021/ci500020m
g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations
R. Kumari (2014)
10.1016/J.IJPHARM.2007.08.001
Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
F. Li (2008)
10.4137/BCBCR.S5857
Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer
P. Vishnu (2011)
Safety and efficacy of nabpaclitaxel in the treatment of patients with breast cancer
P Vishnu (2011)
10.1038/srep11494
EGCG reverses human neutrophil elastase-induced migration in A549 cells by directly binding to HNE and by regulating α1-AT
Yilixiati Xiaokaiti (2015)
10.1016/j.bbamem.2016.02.025
Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylation.
A. Bunker (2016)
10.3390/pharmaceutics4010001
Trojan Microparticles for Drug Delivery
N. Anton (2012)
10.1371/journal.pone.0059106
Investigation of the Interaction of Naringin Palmitate with Bovine Serum Albumin: Spectroscopic Analysis and Molecular Docking
X. Zhang (2013)
10.1016/J.SOFTX.2015.06.001
GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers
M. Abraham (2015)
10.1016/j.jconrel.2014.11.008
Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
S. H. Choi (2015)
10.1016/J.JPBA.2005.08.021
Determination of albuterol sulfate and its related substances in albuterol sulfate inhalation solution, 0.5% by RP-HPLC.
Satyajit V Erram (2006)
10.1016/J.TIBTECH.2007.09.005
Nanoparticles for drug delivery to the lungs.
Jean Sung (2007)
10.1016/j.ejps.2011.09.014
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.
N. El-gendy (2011)
10.1016/j.ijpharm.2015.02.018
Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.
L. Zhao (2015)
10.1002/bio.3135
Fluorescence spectroscopy and molecular simulation on the interaction of caffeic acid with human serum albumin.
Yuhong Xiang (2016)
10.1021/acs.molpharmaceut.5b00318
Advanced Glycation End Products Modulate Structure and Drug Binding Properties of Albumin.
Saurabh Awasthi (2015)
10.1002/minf.201100135
Free Energy Calculations by the Molecular Mechanics Poisson−Boltzmann Surface Area Method
Nadine Homeyer (2012)
10.1517/17460441.2013.777424
In silico prediction of human serum albumin binding for drug leads
Theodosia Vallianatou (2013)
10.1063/1.464397
Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems
T. Darden (1993)
10.1186/s12951-015-0082-8
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model
Lubna Noorani (2015)
10.1053/RMED.2001.1276
Evolution of dry powder inhaler design, formulation, and performance.
S. Newman (2002)
10.1371/journal.pone.0118274
Elucidating the Influence of Gold Nanoparticles on the Binding of Salvianolic Acid B and Rosmarinic Acid to Bovine Serum Albumin
Xin Peng (2015)
10.1110/PS.8.10.1982
Local water bridges and protein conformational stability
M. Petukhov (1999)
10.3390/ijms15033580
Interactive Association of Drugs Binding to Human Serum Albumin
Feng Yang (2014)
10.1371/journal.pone.0086317
BSA Nanoparticle Loaded Atorvastatin Calcium - A New Facet for an Old Drug
Sripriyalakshmi. S (2014)
Gaussian 03 [software]. Wallingford (CT): Gaussian Inc
Mj Frisch (2004)
10.1093/PROTEIN/10.9.999
Hydrogen bonds and salt bridges across protein-protein interfaces.
D. Xu (1997)
10.1063/1.445869
Comparison of simple potential functions for simulating liquid water
W. Jorgensen (1983)
10.1016/j.fob.2015.06.011
Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation
Mikiya Satoh (2015)
10.1016/j.chroma.2008.09.080
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.
K. S. Joseph (2009)
10.1016/j.colsurfb.2009.08.049
Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension.
R. Tantra (2010)
10.1016/j.bbamem.2016.02.015
Computational studies of transport in ion channels using metadynamics.
S. Furini (2016)
10.2147/dddt
Drug Design, Development and Therapy
Z. Cai (2012)
Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver target
FQ Li (2008)
10.1016/j.jphotobiol.2015.03.001
Arsenic trioxide binding to serum proteins.
Sara Shooshtary (2015)
10.1073/PNAS.0506440102
Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.
J. R. Simard (2005)
10.1073/pnas.181342398
Electrostatics of nanosystems: Application to microtubules and the ribosome
Nathan A. Baker (2001)
10.2147/DDDT.S81934
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses
A. Singh (2015)
10.1186/1756-0500-5-367
ACPYPE - AnteChamber PYthon Parser interfacE
A. W. Sousa da Silva (2012)
10.1093/bioinformatics/bts310
DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment
A. Volkamer (2012)
10.1016/J.JMB.2006.06.028
Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
J. R. Simard (2006)
10.1016/j.jconrel.2008.05.010
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
10.1110/PS.9.8.1455
Five recombinant fragments of human serum albumin—tools for the characterization of the warfarin binding site
M. Dockal (2000)
10.3390/s150510481
Surface Plasmon Resonance: A Versatile Technique for Biosensor Applications
H. H. Nguyen (2015)
10.1002/jcc.20035
Development and testing of a general amber force field
J. Wang (2004)
10.1063/1.328693
Polymorphic transitions in single crystals: A new molecular dynamics method
M. Parrinello (1981)
10.1002/jssc.200800567
Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography.
Mandi L Conrad (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar